Evolution of drugs and Drug Labs

Drug evolution is a unique idea that is put out to create chemical libraries with a high likelihood of discovering medications or drug candidates. Chemical evolution replaces biological evolution as a result. In this study, we present "hybridization" drug evolution, which in biological evolution is comparable to sexual recombination of parental genomes. No drug development can take place without the hybridization, which essentially shuffles the components of the parent medicines and ought to drug(s). We created 16 compounds by combining the two parent medications, benzocaine and metoclopramide, with four other known pharmaceuticals and two more molecules with recognised therapeutic properties. The exceptionally large number of medications and drug prospects in the library raises hopes that the final eight chemicals will provide new pharmaceuticals or drug candidates.

    Related Conference of Evolution of drugs and Drug Labs

    September 15-16, 2025

    29th Global Congress on Biotechnology

    Paris, France
    December 04-05, 2025

    9th International Conference on Protein Engineering

    Paris, France
    December 11-12, 2025

    7th International Conference on Biochemistry

    Prague, Czech Republic
    December 22-23, 2025

    29th World Congress on Biotechnology

    Barcelona, Spain
    April 27-28, 2026

    7th Annual Congress on Biosimilars and Future Biotherapeutics

    Paris, Aland Islands
    April 27-28, 2026

    32nd Asia Pacific Biotechnology Congress

    Dubai, UAE

    Evolution of drugs and Drug Labs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in